Dr Haamid Jan

Welcome to Dr Haamid Jan's institution, located at Chermside, Gympie Road, 956. Dr Haamid Jan is a highly experienced medical oncologist practicing at Icon Cancer Centre North Lakes, Wesley, and Chermside in Australia. With a special focus on lung cancer, gastrointestinal cancers, melanoma, and rare neuroendocrine tumors, Dr Jan is dedicated to providing the best possible care to his patients.

Dr Jan's expertise lies in the field of novel immunotherapies and targeted therapies that have revolutionized the landscape of cancer treatment, particularly in metastatic disease. He stays updated with the latest advancements and breakthroughs in oncology to ensure his patients receive the most effective and personalized treatment options available.

After completing his graduation, Dr Jan gained valuable clinical exposure at St. George's University Hospital in London, where he first encountered the management of cancer. He then pursued basic and advanced training in medical oncology at the prestigious Royal Brisbane and Women's Hospital in Queensland, ultimately completing his fellowship in 2014. During his training, he also gained experience in palliative care, emphasizing the importance of holistic patient care.

Dr Jan's dedication to advancing the field of oncology is evident through his research contributions. He presented his research on the survival outcomes of metastatic neuroendocrine tumors in Queensland after treatment with Lutate-177 at the Annual European Neuroendocrine conference in Barcelona in 2015. Additionally, he has conducted extensive research comparing the outcomes of lung cancer management between regional and metropolitan centers in Australia.

As a part of his commitment to advancing cancer research, Dr Jan is currently involved in two important studies. The first study focuses on comparing the investigational drug HBI-8000 combined with Nivolumab versus Nivolumab alone in patients with advanced melanoma. The second study, known as COSTAR Lung, investigates the efficacy of Cobolimab in combination with Dostarlimab and Docetaxel in advanced non-small cell lung cancer participants.

At Dr Haamid Jan's institution, patients can expect compassionate care, personalized treatment plans, and access to the latest advancements in cancer treatment. Whether you are seeking treatment for lung cancer, gastrointestinal cancers, melanoma, or rare neuroendocrine tumors, Dr Jan's expertise and dedication to his patients' well-being make him a trusted choice for your healthcare needs.